Northwest Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Feb '25 Feb 27, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	364	822	830	663	1,255	129	Upgrade
Market Cap Growth	-60.56%	-1.00%	25.14%	-47.13%	870.89%	20.18%	Upgrade
Enterprise Value	435	881	865	686	1,270	146	Upgrade
Last Close Price	0.27	0.70	0.78	0.70	1.52	0.21	Upgrade
PE Ratio	-	-	-	3.70	-	-	Upgrade
PS Ratio	202.42	425.38	493.23	660.03	971.84	53.62	Upgrade
PB Ratio	-6.38	-17.47	-7.90	-5.35	-3.46	-2.87	Upgrade
EV/Sales Ratio	272.45	455.93	513.96	682.10	983.37	60.50	Upgrade
Debt / Equity Ratio	-0.91	-0.97	-0.25	-0.31	-0.05	-0.40	Upgrade
Asset Turnover	0.05	0.07	0.05	0.03	0.06	0.14	Upgrade
Quick Ratio	0.05	0.05	0.06	0.11	0.03	0.01	Upgrade
Current Ratio	0.09	0.09	0.07	0.13	0.04	0.07	Upgrade
Return on Assets (ROA)	-129.81%	-117.23%	-117.48%	-90.17%	-248.62%	-99.05%	Upgrade
Earnings Yield	-19.53%	-7.62%	-12.65%	27.00%	-42.23%	-16.11%	Upgrade
FCF Yield	-15.17%	-6.94%	-6.71%	-6.68%	-3.08%	-24.93%	Upgrade
Buyback Yield / Dilution	-10.13%	-10.17%	-0.79%	-38.99%	-28.53%	-28.22%	Upgrade
Total Shareholder Return	-10.13%	-10.17%	-0.79%	-38.99%	-28.53%	-28.22%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.